Isra Dmour

833 total citations
24 papers, 577 citations indexed

About

Isra Dmour is a scholar working on Pharmaceutical Science, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Isra Dmour has authored 24 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 6 papers in Pharmacology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Isra Dmour's work include Pharmacogenetics and Drug Metabolism (6 papers), Advanced Drug Delivery Systems (6 papers) and Pharmaceutical studies and practices (5 papers). Isra Dmour is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Advanced Drug Delivery Systems (6 papers) and Pharmaceutical studies and practices (5 papers). Isra Dmour collaborates with scholars based in Jordan, Russia and Australia. Isra Dmour's co-authors include Mutasem O. Taha, Nazrul Islam, Nazrul Islam, Naji M. Najib, Ruwayda Dham, Nasir Idkaidek, Qamar uz Zaman, Gilberto De Nucci, Baba Sulemana Mohammed and Inshad Jum’h and has published in prestigious journals such as Carbohydrate Polymers, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

Isra Dmour

21 papers receiving 563 citations

Peers

Isra Dmour
S. V. Fulzele India
Mutasem Rawas‐Qalaji United Arab Emirates
Poonam Parashar India
Shahla Mirzaeei Iran
Renuka S. Managuli India
Shefaat Ullah Shah Pakistan
Cláudia Maria Oliveira Simões Brazil
Majed Alrobaian Saudi Arabia
Ion Mircioiu Romania
Himanshu Agrawal India
S. V. Fulzele India
Isra Dmour
Citations per year, relative to Isra Dmour Isra Dmour (= 1×) peers S. V. Fulzele

Countries citing papers authored by Isra Dmour

Since Specialization
Citations

This map shows the geographic impact of Isra Dmour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isra Dmour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isra Dmour more than expected).

Fields of papers citing papers by Isra Dmour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isra Dmour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isra Dmour. The network helps show where Isra Dmour may publish in the future.

Co-authorship network of co-authors of Isra Dmour

This figure shows the co-authorship network connecting the top 25 collaborators of Isra Dmour. A scholar is included among the top collaborators of Isra Dmour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isra Dmour. Isra Dmour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dmour, Isra, et al.. (2024). Preparation of novel shell-ionotropically crosslinked micelles based on hexadecylamine and tripolyphosphate for cancer drug delivery. Pharmaceutical Development and Technology. 29(4). 322–338. 1 indexed citations
4.
5.
Dmour, Isra & Mutasem O. Taha. (2023). Tableting-induced mechanochemical matrix crosslinking: Towards non-disintegrating chitosan-based sustained delivery tablets. Journal of Drug Delivery Science and Technology. 86. 104696–104696. 2 indexed citations
6.
Dmour, Isra, et al.. (2023). Diuretics misuse: A cross-sectional study to explore community pharmacist’s perceptions of diuretics use and misuse. Journal of Applied Pharmaceutical Science. 1 indexed citations
7.
Dmour, Isra, et al.. (2023). Self-care interventions among the Jordanians during the COVID-19 lockdown: A cross-sectional study of community pharmacists’ observations. Journal of Applied Pharmaceutical Science. 1 indexed citations
8.
9.
Dmour, Isra & Nazrul Islam. (2021). Recent advances on chitosan as an adjuvant for vaccine delivery. International Journal of Biological Macromolecules. 200. 498–519. 75 indexed citations
10.
11.
Islam, Nazrul, Isra Dmour, & Mutasem O. Taha. (2019). Degradability of chitosan micro/nanoparticles for pulmonary drug delivery. Heliyon. 5(5). e01684–e01684. 203 indexed citations
12.
Najib, Naji M., et al.. (2004). Comparative bioavailability of two brands of atenolol 100 mg tablets (Tensotin and Tenormin) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 26(1). 1–5. 6 indexed citations
13.
Najib, Naji M., et al.. (2004). Bioequivalence assessment of Lovrak (Julphar, UAE) compared with Zovirax (Glaxo Wellcome, UK)‐Two brands of Acyclovir‐in healthy human volunteers. Biopharmaceutics & Drug Disposition. 26(1). 7–12. 8 indexed citations
14.
Najib, Naji M., et al.. (2004). Bioequivalence evaluation of two brands of aceclofenac 100mg tablets (Aceclofar and Bristaflam) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 25(3). 103–108. 14 indexed citations
15.
Najib, Naji M., et al.. (2003). Pharmacokinetics and bioequivalence evaluation of two simvastatin 40 mg tablets (Simvast & Zocor) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 24(5). 183–189. 36 indexed citations
16.
Najib, Naji M., et al.. (2003). Bioequivalence evaluation of two brands of furosemide 40mg tablets (Salurin and Lasix) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 24(6). 245–249. 8 indexed citations
17.
Najib, Naji M., et al.. (2003). Bioequivalence evaluation of two brands of enalapril 20mg tablets (narapril and renitec) in healthy human volunteers. Biopharmaceutics & Drug Disposition. 24(7). 315–320. 17 indexed citations
18.
Najib, Naji M., et al.. (2002). Bioequivalence evaluation of two brands of metformin 500 mg tablets (Dialon® & Glucophage®) – in healthy human volunteers. Biopharmaceutics & Drug Disposition. 23(7). 301–306. 23 indexed citations
19.
Najib, Naji M., et al.. (2002). Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide® & Diamicron®) — in healthy human volunteers. Biopharmaceutics & Drug Disposition. 23(5). 197–202. 16 indexed citations
20.
Najib, Naji M., et al.. (2001). Bioequivalence assessment of Azomycin® (Julphar, UAE) as compared to Zithromax® (Pfizer, USA)—two brands of azithromycin—in healthy human volunteers. Biopharmaceutics & Drug Disposition. 22(1). 15–21. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. V. Fulzele Breakdown of academic impact, for papers by Mutasem Rawas‐Qalaji Breakdown of academic impact, for papers by Poonam Parashar Breakdown of academic impact, for papers by Shahla Mirzaeei Breakdown of academic impact, for papers by Renuka S. Managuli Breakdown of academic impact, for papers by Shefaat Ullah Shah Breakdown of academic impact, for papers by Cláudia Maria Oliveira Simões Breakdown of academic impact, for papers by Majed Alrobaian Breakdown of academic impact, for papers by Ion Mircioiu Breakdown of academic impact, for papers by Himanshu Agrawal
Rankless by CCL
2026